The Food & Drug Administration is doling out $72 million to Wellesley, Mass.-based Harvard Pilgrim Health Care Inc. for a pilot of the agency’s Sentinel System for monitoring healthcare data.
The system will use automatically reported healthcare data collected by physicians and nurses in the field to better identify safety issues with medical products and drugs. The agreement is for one year and includes four renewable years, for a total of $72 million.